Cytomos secures £5 million of scale-up investment

Written By Lesley Parsons

Cytomos has raised £5m to scale up production of its cell analysis technology.

The oversubscribed funding round was led by existing investors Archangels, with participation from Old College Capital, Scottish Enterprise and the British Business Bank.

New investment will allow the Edinburgh-based biotechnology company to drive sales of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.

Lesley Parsons
Previous

Cytomos secures £5 million for scale-up
Next

Cream of Scotland's dealmaking community celebrated at inaugural awards in Edinburgh